62 Participants Needed

Tranexamic Acid vs Thrombin for Skin Graft Complications

JR
Overseen ByJessica Reynolds, BSN
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial
Approved in 5 JurisdictionsThis treatment is already approved in other countries

Trial Summary

Do I need to stop my current medications for the trial?

The trial information does not specify if you need to stop taking your current medications. However, if you are on immunosuppression, you cannot participate in the trial.

What data supports the effectiveness of the drug Tranexamic Acid for reducing complications in skin grafts?

Research shows that Tranexamic Acid (TXA) is effective in reducing blood loss and the need for blood transfusions in various surgeries, including craniofacial and orthognathic surgeries. This suggests it may help reduce bleeding complications in skin graft procedures as well.12345

Is Tranexamic Acid generally safe for use in humans?

Tranexamic Acid (TXA) is generally considered safe for use in various surgeries, with studies showing it effectively reduces blood loss and transfusion needs. However, it may increase the risk of seizures in cardiac surgery, and there are isolated reports of vascular issues like ulnar artery thrombosis. Overall, TXA has few adverse events, but more research is needed for certain surgical areas.12467

How is the drug Tranexamic Acid different from other treatments for skin graft complications?

Tranexamic Acid (TXA) is unique because it helps prevent bleeding by stopping the breakdown of blood clots, which can be particularly useful in surgeries where bleeding is a concern. Unlike other treatments, TXA is an antifibrinolytic agent, meaning it specifically targets and reduces bleeding, making it a novel option for managing complications in skin grafts.14589

What is the purpose of this trial?

Investigators hypothesize that topical tranexamic acid will have better or comparable efficacy to topical thrombin in reducing hematoma formation at the wound base. The purpose of the study is to demonstrate that topical tranexamic acid will be a non-inferior alternative medication to the current standard of care,THROMBIN-JMI® , and at a lower cost to the health system.

Research Team

DB

Dhaval Bhavsar, MD

Principal Investigator

The University of Kansas Medical Center

Eligibility Criteria

This trial is for English or Spanish speakers with flame or scald burns covering 10% or less of their body. They must have a partial thickness burn and require a skin graft that's either meshed 1:1 or pie crusted if it's a small area, but not more than 5% deep partial/full thickness.

Inclusion Criteria

I have a burn injury from fire or hot liquid.
Less than 10% of my body has partial thickness burns.
My skin graft was taken at a specific depth and prepared in a certain way.
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Participants undergo surgery with either tranexamic acid or thrombin applied to the wound base during split thickness skin grafting

1 day
1 visit (in-person, surgical procedure)

Post-operative Care

Participants receive routine post-operative care in the burn unit with assessments at 48-72 hours, 7-10 days, and 14 days post-surgery

2 weeks
3 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment, including hematoma occurrence and graft adherence

2 weeks

Treatment Details

Interventions

  • Thrombin JMI
  • Tranexamic Acid
Trial Overview The study is testing whether topical Tranexamic acid can be as effective as the standard Thrombin JMI in reducing hematoma formation under skin grafts after burns, potentially offering a cheaper option for treatment.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: ExperimentalExperimental Treatment2 Interventions
Tranexamic acid solution will be sprayed onto the wound base after excision and prior to skin graft appliance in the same manner as the thrombin spray in the control group
Group II: ControlActive Control2 Interventions
Prior to application of the skin graft, a thin layer of thrombin is sprayed onto the wound base. The skin graft is then applied to the recipient site and fixated in standard fashion.

Tranexamic Acid is already approved in United States, European Union, Canada, Japan for the following indications:

🇺🇸
Approved in United States as Tranexamic Acid for:
  • Heavy menstrual bleeding
  • Prevention of excessive bleeding during surgeries
🇪🇺
Approved in European Union as Tranexamic Acid for:
  • Heavy menstrual bleeding
  • Prevention of excessive bleeding during surgeries
  • Hereditary angioedema
🇨🇦
Approved in Canada as Tranexamic Acid for:
  • Heavy menstrual bleeding
  • Prevention of excessive bleeding during surgeries
🇯🇵
Approved in Japan as Tranexamic Acid for:
  • Heavy menstrual bleeding
  • Prevention of excessive bleeding during surgeries

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Kansas Medical Center

Lead Sponsor

Trials
527
Recruited
181,000+

Findings from Research

Tranexamic acid (TXA) can effectively reduce blood loss and the need for transfusions during pediatric craniosynostosis repair surgeries, which is important for improving surgical outcomes.
However, there are safety concerns associated with TXA, as demonstrated by a case of ulnar artery thrombosis in a patient who received TXA during cranial vault reconstructive surgery, highlighting the need for careful monitoring when using this medication.
Ulnar Artery Thrombosis Following Tranexamic Acid Administration for Craniosynostosis Repair.Chung, E., Karlberg, HI.[2019]
Tranexamic acid (TXA) significantly reduces blood loss and transfusion requirements in craniofacial and orthognathic surgeries, with reductions of 18.2 mL/kg and 156 mL respectively, based on a systematic review of 14 studies involving 7965 records.
While TXA shows promise in other plastic surgery areas like breast and reconstructive microsurgery, there is currently a lack of high-quality evidence (Level-1) for its efficacy in these fields, highlighting the need for further research.
The Efficacy and Safety of Tranexamic Acid in Cranio-Maxillofacial and Plastic Surgery.Murphy, GR., Glass, GE., Jain, A.[2022]
In a study of 44 patients undergoing deep-plane facelifts, intravenous tranexamic acid (TXA) was associated with decreased postoperative bruising and collections, indicating it may improve recovery outcomes.
While TXA did not significantly reduce intraoperative bleeding, it was found to be safe and could be a beneficial addition to surgical protocols, warranting further investigation.
Effects of Intravenous Tranexamic Acid During Rhytidectomy: A Randomized, Controlled, Double-Blind Pilot Study.Cohen, JC., Glasgold, RA., Alloju, LM., et al.[2021]

References

Ulnar Artery Thrombosis Following Tranexamic Acid Administration for Craniosynostosis Repair. [2019]
The Efficacy and Safety of Tranexamic Acid in Cranio-Maxillofacial and Plastic Surgery. [2022]
Effects of Intravenous Tranexamic Acid During Rhytidectomy: A Randomized, Controlled, Double-Blind Pilot Study. [2021]
Tranexamic Acid Prevention of Hemorrhagic Complications Following Interpolated Flap Repair: A Single-Center, Retrospective, Cohort Study. [2023]
Efficacy of tranexamic acid on side effects of rhinoplasty: A randomized double-blind study. [2018]
Tranexamic acid administration for anatomic and reverse total shoulder arthroplasty: a systematic review and meta-analysis. [2022]
Does Tranexamic Acid Reduce the Blood Loss in Various Surgeries? An Umbrella Review of State-of-the-Art Meta-Analysis. [2022]
Q-Switched Nd:YAG (532 nm) Laser Versus Intra-Dermal Tranexamic Acid for Treatment of Facial Ephelides: A Split Face, Randomized, Comparative Trial. [2022]
Local Infiltration of Tranexamic Acid (TXA) in Liposuction: A Single-Surgeon Outcomes Analysis and Considerations for Minimizing Postoperative Donor Site Ecchymosis. [2021]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security